Teijin enters into strategic partnership with InCube Labs

Teijin Limited announced that it has signed a strategic partnership agreement with InCube Labs, a California-based life science research lab, to accelerate Teijin's healthcare business development.  

As part of the agreement, Teijin will invest in a company affiliated with InCube Labs. By leveraging its extensive network and expertise, InCube Labs will help Teijin to define strategic growth opportunities for its healthcare business.  

Initiatives will include competitive evaluation of Teijin technologies, analysis of key market characteristics and regulations, and provision of information to help Teijin identify promising business partners and M&A opportunities. 

Healthcare is one of the growth drivers in the Teijin group's medium- to long-term management vision. The group plans to integrate its materials and healthcare technologies to facilitate its expansion into fields including regenerative medicine and tissue repair, drug delivery systems and locomotive syndrome. 

"To help us expand our healthcare business and create solutions for unmet medical needs, we sought a partner with deep understanding of the healthcare market, including technologies and business opportunities," said Kazuo Imose, Teijin Group Corporate Officer and General Manager of the New Business Incubation and Development Division.  

"InCube Labs' extensive knowledge and track record in healthcare innovation and company formation, including in the fields of medical instruments and materials, will be a tremendous asset as we pursue opportunities in the healthcare domain."